Baak, J. P. A., Path, F. R. C., Hermsen, M. A. J. A., Meijer, G., Schmidt, J., & Janssen, E. A. M. (2003). Genomics and proteomics in cancer. European Journal of Cancer, 39(9), 1199-1215. doi:10.1016/S0959-8049(03)00265-X
Baskin, Y. (2007). TIPTA TEKNOLOJİK GELİŞİMİN NEDEN OLDUĞU KAVRAM DEĞİŞİMLERİ: KİŞİSELLEŞTİRİLMİŞ TIP changes in concepts of the technological progress: Personalized medicine. Turk Hij.Den.Biyol.Derg, 64, 54-59. Retrieved from www.scopus.com
Beretov, J., Wasinger, V. C., Millar, E. K. A., Schwartz, P., Graham, P. H., & Li, Y. (2015). Proteomic analysis of urine to identify breast cancer biomarker candidates using a label-free LC-MS/MS approach. PLoS ONE, 10(11) doi:10.1371/journal.pone.0141876
Bingle, L., Cross, S. S., High, A. S., Wallace, W. A., Rassl, D., Yuan, G., . . . Bingle, C. D. (2006). WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respiratory Research, 7 doi:10.1186/1465-9921-7-61
Bingle, L., Singleton, V., & Bingle, C. D. (2002). The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms. Oncogene, 21(17), 2768-2773. doi:10.1038/sj.onc.1205363
Bleicher, K. H., Böhm, H. -., Müller, K., & Alanine, A. I. (2003). Hit and lead generation: Beyond high-throughput screening. Nature Reviews Drug Discovery, 2(5), 369-378. doi:10.1038/nrd1086
Burbaum, J., & Tobal, G. M. (2002). Proteomics in drug discovery. Current Opinion in Chemical Biology, 6(4), 427-433. doi:10.1016/S1367-5931(02)00337-X
Chakraborti, S., Natarajan, K., Curiel, J., Janke, C., & Liu, J. (2016). The emerging role of the tubulin code: From the tubulin molecule to neuronal function and disease. Cytoskeleton, 73(10), 521-550. doi:10.1002/cm.21290
Dowling, P., Meleady, P., Dowd, A., Henry, M., Glynn, S., & Clynes, M. (2007). Proteomic analysis of isolated membrane fractions from superinvasive cancer cells. Biochimica Et Biophysica Acta - Proteins and Proteomics, 1774(1), 93-101. doi:10.1016/j.bbapap.2006.09.014
Elmore, S. (2007). Apoptosis: A review of programmed cell death. Toxicologic Pathology, 35(4), 495-516. doi:10.1080/01926230701320337
España, L., Martín, B., Aragüés, R., Chiva, C., Oliva, B., Andreu, D., & Sierra, A. (2005). Bcl-xL-mediated changes in metabolic pathways of breast cancer cells: From survival in the blood stream to organ-specific metastasis. American Journal of Pathology, 167(4), 1125-1137. doi:10.1016/S0002-9440(10)61201-1
Friedl, P., Locker, J., Sahai, E., & Segall, J. E. (2012). Classifying collective cancer cell invasion. Nature Cell Biology, 14(8), 777-783. doi:10.1038/ncb2548
Friedl, P., & Wolf, K. (2010). Plasticity of cell migration: A multiscale tuning model. Journal of Cell Biology, 188(1), 11-19. doi:10.1083/jcb.200909003
Fuchs, E. (1988). Keratins as biochemical markers of epithelial differentiation. Trends in Genetics, 4(10), 277-281. doi:10.1016/0168-9525(88)90169-2
Gadadhar, S., Bodakuntla, S., Natarajan, K., & Janke, C. (2017). The tubulin code at a glance. Journal of Cell Science, 130(8), 1347-1353. doi:10.1242/jcs.199471
Garrett, R. H., & Grisham, C. M. (1995). Biochemistry, Retrieved from www.scopus.com
Gromov, P. S., Østergaard, M., Gromova, I., & Celis, J. E. (2002). Human proteomic databases: A powerful resource for functional genomics in health and disease. Progress in Biophysics and Molecular Biology, 80(1-2), 3-22. doi:10.1016/S0079-6107(02)00005-6
Gündüz, U. R., Gunaldi, M., Isiksacan, N., Gündüz, S., Okuturlar, Y., & Kocoglu, H. (2016). A new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study. Mol Clin Oncol, 5(2), 355-360. Retrieved from www.scopus.com
Hamidu, A., Mokrish, A., Mansor, R., Razak, I. S. A., Danmaigoro, A., Jaji, A. Z., & Bakar, Z. A. (2019). Modified methods of nanoparticles synthesis in ph-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line. International Journal of Nanomedicine, 14, 3615-3627. doi:10.2147/IJN.S190830
Haruta, S., Hanafusa, T., Fukase, H., Miyajima, H., & Oki, T. (2003). An effective absorption behavior of insulin for diabetic treatment following intranasal delivery using porous spherical calcium carbonate in monkeys and healthy human volunteers. Diabetes Technology and Therapeutics, 5(1), 1-9. doi:10.1089/152091503763816409
Hicks, D. G., & Kulkarni, S. (2008). HER2+ breast cancer: Review of biologic relevance and optimal use of diagnostic tools. American Journal of Clinical Pathology, 129(2), 263-273. doi:10.1309/99AE032R9FM8WND1
Hsu, K. -., & Kao, H. -. (2013). Alpha-actinin 4 and tumorigenesis of breast cancer doi:10.1016/B978-0-12-416673-8.00005-8 Retrieved from www.scopus.com
Janke, C. (2014). The tubulin code: Molecular components, readout mechanisms, functions. Journal of Cell Biology, 206(4), 461-472. doi:10.1083/jcb.201406055
Kamba, S. A., Ismail, M., Hussein-Al-Ali, S. H., Ibrahim, T. A. T., & Zakaria, Z. A. B. (2013). In vitro delivery and controlled release of doxorubicin for targeting osteosarcoma bone cancer. Molecules, 18(9), 10580-10598. doi:10.3390/molecules180910580
Kamei, M., Yamashita, S. -., Tokuishi, K., Hashioto, T., Moroga, T., Suehiro, S., . . . Kawahara, K. (2010). HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer. Anticancer Research, 30(11), 4779-4783. Retrieved from www.scopus.com
Karantza, V. (2011). Keratins in health and cancer: More than mere epithelial cell markers. Oncogene, 30(2), 127-138. doi:10.1038/onc.2010.456
Kiso, M., Tanaka, S., Saji, S., Toi, M., & Sato, F. (2018). Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network. International Journal of Cancer, 143(11), 2905-2918. doi:10.1002/ijc.31645
Kondo, T., Oka, T., Sato, H., Shinnou, Y., Washio, K., Takano, M., . . . Yoshino, T. (2009). Accumulation of aberrant CpG hypermethylation by helicobacter pylori infection promotes development and progression of gastric MALT lymphoma. International Journal of Oncology, 35(3), 547-557. doi:10.3892/ijo_00000366
Kooijmans, S. A. A., Gitz-Francois, J. J. J. M., Schiffelers, R. M., & Vader, P. (2018). Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: A plug-and-play approach. Nanoscale, 10(5), 2413-2426. doi:10.1039/c7nr06966a
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011). Otto warburg's contributions to current concepts of cancer metabolism. Nature Reviews Cancer, 11(5), 325-337. doi:10.1038/nrc3038
Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44(1), 235-249. doi:10.1016/S1056-8719(00)00107-6
Liu, K., Tang, Z., Huang, A., Chen, P., Liu, P., Yang, J., . . . Huang, P. (2017). Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression. International Journal of Oncology, 50(1), 252-262. doi:10.3892/ijo.2016.3774
Mahmood, R. I., Abbass, A. K., Al-Saffar, A. Z., & Al-Obaidi, J. R. (2021). An in vitro cytotoxicity of a novel pH-sensitive lectin loaded-cockle shell-derived calcium carbonate nanoparticles against MCF-7 breast tumour cell. Journal of Drug Delivery Science and Technology, 61 doi:10.1016/j.jddst.2020.102230
Mahmood, R. I., Abbass, A. K., Razali, N., Al-Saffar, A. Z., & Al-Obaidi, J. R. (2021). Protein profile of MCF-7 breast cancer cell line treated with lectin delivered by CaCO3NPs revealed changes in molecular chaperones, cytoskeleton, and membrane-associated proteins. International Journal of Biological Macromolecules, 184, 636-647. doi:10.1016/j.ijbiomac.2021.06.144
Maleki Dizaj, S., Barzegar-Jalali, M., Zarrintan, M. H., Adibkia, K., & Lotfipour, F. (2015). Calcium carbonate nanoparticles as cancer drug delivery system. Expert Opinion on Drug Delivery, 12(10), 1649-1660. doi:10.1517/17425247.2015.1049530
Mariani, M., Karki, R., Spennato, M., Pandya, D., He, S., Andreoli, M., . . . Ferlini, C. (2015). Clas- III β-tubulin in normal and cancer tissues. Gene, 563(2), 109-114. doi:10.1016/j.gene.2015.03.061
Moore, R. G., McMeekin, D. S., Brown, A. K., DiSilvestro, P., Miller, M. C., Allard, W. J., . . . Skates, S. J. (2009). A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecologic Oncology, 112(1), 40-46. doi:10.1016/j.ygyno.2008.08.031
Mori, R., Wang, Q., Danenberg, K. D., Pinski, J. K., & Danenberg, P. V. (2008). Both β-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer. Prostate, 68(14), 1555-1560. doi:10.1002/pros.20815
Palmieri, F. (2014). Mitochondrial transporters of the SLC25 family and associated diseases: A review. Journal of Inherited Metabolic Disease, 37(4), 565-575. doi:10.1007/s10545-014-9708-5
Palmieri, F., & Monné, M. (2016). Discoveries, metabolic roles and diseases of mitochondrial carriers: A review. Biochimica Et Biophysica Acta - Molecular Cell Research, 1863(10), 2362-2378. doi:10.1016/j.bbamcr.2016.03.007
Pick, E., Kluger, Y., Giltnane, J. M., Moeder, C., Camp, R. L., Rimm, D. L., & Kluger, H. M. (2007). High HSP90 expression is associated with decreased survival in breast cancer. Cancer Research, 67(7), 2932-2937. doi:10.1158/0008-5472.CAN-06-4511
Piovano, E., Attamante, L., Macchi, C., Cavallero, C., Romagnolo, C., Maggino, T., . . . Zola, P. (2014). The role of HE4 in ovarian cancer follow-up: A review. International Journal of Gynecological Cancer, 24(8), 1359-1365. doi:10.1097/IGC.0000000000000218
Qian, K., Shi, T., Tang, T., Zhang, S., Liu, X., & Cao, Y. (2011). Preparation and characterization of nano-sized calcium carbonate as controlled release pesticide carrier for validamycin against rhizoctonia solani. Microchimica Acta, 173(1-2), 51-57. doi:10.1007/s00604-010-0523-x
Razali, N., Aziz, A. A., Lim, C. Y., & Junit, S. M. (2015). Investigation into the effects of antioxidant-rich extract of tamarindus indica leaf on antioxidant enzyme activities, oxidative stress and gene expression profiles in HepG2 cells. PeerJ, 2015(10) doi:10.7717/peerj.1292
Révillion, F., Pawlowski, V., Hornez, L., & Peyrat, J. -. (2000). Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer. European Journal of Cancer, 36(8), 1038-1042. doi:10.1016/S0959-8049(00)00051-4
Savino, R., Paduano, S., Preianò, M., & Terracciano, R. (2012). The proteomics big challenge for biomarkers and new drug-targets discovery. International Journal of Molecular Sciences, 13(11), 13926-13948. doi:10.3390/ijms131113926
Seyfried, T. N., & Shelton, L. M. (2010). Cancer as a metabolic disease. Nutrition and Metabolism, 7 doi:10.1186/1743-7075-7-7
Shortrede, J. E., Uzair, I. D., Neira, F. J., Flamini, M. I., & Sanchez, A. M. (2016). Paxillin, a novel controller in the signaling of estrogen to FAK/N-WASP/Arp2/3 complex in breast cancer cells. Molecular and Cellular Endocrinology, 430, 56-67. doi:10.1016/j.mce.2016.04.007
Singh, S. K., Singh, S., Wlillard, J., Jr., & Singh, R. (2017). Drug delivery approaches for breast cancer. International Journal of Nanomedicine, 12, 6205-6218. doi:10.2147/IJN.S140325
Song, S., & Finkel, T. (2007). GAPDH and the search for alternative energy. Nature Cell Biology, 9(8), 869-870. doi:10.1038/ncb0807-869
Steiner, C., Ducret, A., Tille, J. -., Thomas, M., Mckee, T. A., Rubbia-Brandt, L., . . . Cutler, P. (2014). Applications of mass spectrometry for quantitative protein analysis in formalin-fixed paraffin-embedded tissues. Proteomics, 14(4-5), 441-451. doi:10.1002/pmic.201300311
Tang, K. D., Kenny, L., Perry, C., Frazer, I., & Punyadeera, C. (2017). The overexpression of salivary cytokeratins as potential diagnostic biomarkers in head and neck squamous cell carcinomas. Oncotarget, 8(42), 72272-72280. doi:10.18632/oncotarget.19731
Thapa, N. (2019). Self-dual leonard pairs ATP synthase: Structure, function and inhibition. Biomol.Concepts, 10, 1-10. Retrieved from www.scopus.com
Troussard, A. A., McDonald, P. C., Wederell, E. D., Mawji, N. M., Filipenko, N. R., Gelmon, K. A., . . . Dedhar, S. (2006). Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Cancer Research, 66(1), 393-403. doi:10.1158/0008-5472.CAN-05-2304
Ueno, Y., Futagawa, H., Takagi, Y., Ueno, A., & Mizushima, Y. (2005). Drug-incorporating calcium carbonate nanoparticles for a new delivery system. Journal of Controlled Release, 103(1), 93-98. doi:10.1016/j.jconrel.2004.11.015
Usuldin, S. R. A., Al-Obaidi, J. R., Razali, N., Junit, S. M., Ajang, M. J., Hussin, S. N. I. S., . . . Saleh, N. M. (2017). Molecular investigation of carrageenan production in kappaphycus alvarezii in different culture conditions: A proteomic approach. Journal of Applied Phycology, 29(4), 1989-2001. doi:10.1007/s10811-017-1119-1
Walker, J. M. (1994). The bicinchoninic acid (BCA) assay for protein quantitation. Methods in Molecular Biology (Clifton, N.J.), 32, 5-8. doi:10.1385/0-89603-268-x:5
Wang, H., Vo, T., Hajar, A., Li, S., Chen, X., Parissenti, A. M., . . . Wang, Z. (2014). Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells. BMC Cancer, 14(1) doi:10.1186/1471-2407-14-37
Wang, S. -., Ju, H. -., Liu, K. -., Zhang, J. -., Wang, X., Xiang, Y. -., . . . Wang, Y. -. (2011). SNX-2112, a novel Hsp90 inhibitor, induces G2/M cell cycle arrest and apoptosis in MCF-7 cells. Bioscience, Biotechnology and Biochemistry, 75(8), 1540-1545. doi:10.1271/bbb.110225
Whitesell, L., & Lindquist, S. L. (2005). HSP90 and the chaperoning of cancer. Nature Reviews Cancer, 5(10), 761-772. doi:10.1038/nrc1716
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015). Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications. Journal of Controlled Release, 200, 138-157. doi:10.1016/j.jconrel.2014.12.030
Workman, P., & Powers, M. V. (2007). Chaperoning cell death: A critical dual role for Hsp90 in small-cell lung cancer. Nature Chemical Biology, 3(8), 455-457. doi:10.1038/nchembio0807-455
Wu, Z., Wu, J., Zhao, Q., Fu, S., & Jin, J. (2020). Emerging roles of aerobic glycolysis in breast cancer. Clinical and Translational Oncology, 22(5), 631-646. doi:10.1007/s12094-019-02187-8
Yamaguchi, H., & Condeelis, J. (2007). Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochimica Et Biophysica Acta - Molecular Cell Research, 1773(5), 642-652. doi:10.1016/j.bbamcr.2006.07.001
Yang, K. -., Bae, E., Ahn, S. G., Pang, K., Park, Y., Park, J., . . . Kim, S. -. (2017). Co-chaperone BAG2 determines the pro-oncogenic role of cathepsin B in triple-negative breast cancer cells. Cell Reports, 21(10), 2952-2964. doi:10.1016/j.celrep.2017.11.026
Yu, L., Chen, X., Wang, L., & Chen, S. (2016). The sweet trap in tumors: Aerobic glycolysis and potential targets for therapy. Oncotarget, 7(25), 38908-38926. doi:10.18632/oncotarget.7676
Zahra, K., Dey, T., Ashish, Mishra, S. P., & Pandey, U. (2020). Pyruvate kinase M2 and cancer: The role of PKM2 in promoting tumorigenesis. Frontiers in Oncology, 10 doi:10.3389/fonc.2020.00159
Zeng, C., Ke, Z., Song, Y., Yao, Y., Hu, X., Zhang, M., . . . Yin, J. (2013). Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the bcl-2/Bax balance. Experimental and Molecular Pathology, 95(1), 23-31. doi:10.1016/j.yexmp.2013.04.002
Zhang, Y. T., Zhang, Y. L., Chen, S. X., Yin, G. H., Yang, Z. Z., Lee, S., . . . Yang, F. S. (2015). Proteomics of methyl jasmonate induced defense response in maize leaves against asian corn borer. BMC Genomics, 16(1) doi:10.1186/s12864-015-1363-1